Primecap Management
LUNG icon

Primecap Management’s Pulmonx LUNG Stock Holding History

Primecap Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6M Sell
4,612,331
-112,660
-2% -$155K ﹤0.01% 284
2026
Q1 		$6.1M Sell
4,724,991
-2,800
-0.1% -$4.63K ﹤0.01% 271
2025
Q4 		$10.4M Sell
4,727,791
-228,900
-5% -$430K 0.01% 256
2025
Q3 		$8.03M Sell
4,956,691
-207,990
-4% -$435K 0.01% 266
2025
Q2 		$13.4M Sell
5,164,681
-250,080
-5% -$986K 0.01% 256
2025
Q1 		$36.4M Sell
5,414,761
-97,530
-2% -$691K 0.03% 203
2024
Q4 		$37.4M Sell
5,512,291
-163,720
-3% -$1.08M 0.03% 206
2024
Q3 		$47.1M Sell
5,676,011
-33,890
-0.6% -$245K 0.03% 190
2024
Q2 		$36.2M Sell
5,709,901
-29,526
-0.5% -$227K 0.03% 202
2024
Q1 		$53.2M Buy
5,739,427
+92,976
+2% +$1.09M 0.04% 187
2023
Q4 		$72M Buy
5,646,451
+124,050
+2% +$1.29M 0.06% 161
2023
Q3 		$57M Buy
5,522,401
+2,680
+0% +$31K 0.05% 168
2023
Q2 		$72.4M Buy
5,519,721
+17,000
+0.3% +$208K 0.06% 160
2023
Q1 		$61.5M Hold
5,502,721
– – 0.05% 164
2022
Q4 		$46.4M Buy
5,502,721
+69,970
+1% +$665K 0.04% 176
2022
Q3 		$90.5M Buy
5,432,751
+35,130
+0.7% +$647K 0.09% 143
2022
Q2 		$79.5M Sell
5,397,621
-48,370
-0.9% -$996K 0.07% 154
2022
Q1 		$135M Buy
5,445,991
+502,100
+10% +$13M 0.1% 133
2021
Q4 		$159M Buy
4,943,891
+1,970,200
+66% +$72M 0.11% 133
2021
Q3 		$107M Buy
2,973,691
+1,014,348
+52% +$39.9M 0.08% 150
2021
Q2 		$86.4M Buy
1,959,343
+767,343
+64% +$33.4M 0.06% 165
2021
Q1 		$54.5M Buy
1,192,000
+459,500
+63% +$26.4M 0.04% 189
2020
Q4 		$50.6M Buy
+732,500
New +$35.9M 0.04% 188

Other funds holding LUNG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Primecap Management's LUNG Position: Q2 2026 in Review

Primecap Management reduced its Pulmonx (LUNG) stake by 2.4% in Q2 2026, selling an estimated $155K and leaving 4,612,331 shares worth $6M. The position accounts for ﹤0.01% of the portfolio, ranked #284.

Primecap Management first reported a position in LUNG in Q4 2020 and has held it in 23 quarters since. The position peaked at $159M in Q4 2021. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Primecap Management held 4,612,331 shares of Pulmonx worth $6M as of Q2 2026.
  • Primecap Management sold 112,660 Pulmonx shares in Q2 2026, an estimated $155K.
  • Pulmonx made up ﹤0.01% of Primecap Management's portfolio in Q2 2026, its #284 holding.
  • Primecap Management first reported a position in Pulmonx in Q4 2020 and has held it in 23 quarters since.
  • Primecap Management's Pulmonx position peaked at $159M in Q4 2021.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Primecap Management's 13F filing for Q2 2026, filed 14 Aug 2026.